IL107268D0 - Molecules influencing the shedding of the tnf receptor, their preparation and their use - Google Patents

Molecules influencing the shedding of the tnf receptor, their preparation and their use

Info

Publication number
IL107268D0
IL107268D0 IL10726893A IL10726893A IL107268D0 IL 107268 D0 IL107268 D0 IL 107268D0 IL 10726893 A IL10726893 A IL 10726893A IL 10726893 A IL10726893 A IL 10726893A IL 107268 D0 IL107268 D0 IL 107268D0
Authority
IL
Israel
Prior art keywords
shedding
preparation
use
tnf receptor
molecules influencing
Prior art date
Application number
IL10726893A
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Priority to IL10726893A priority Critical patent/IL107268D0/en
Publication of IL107268D0 publication Critical patent/IL107268D0/en

Links

IL10726893A 1993-10-12 1993-10-12 Molecules influencing the shedding of the tnf receptor, their preparation and their use IL107268D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL10726893A IL107268D0 (en) 1993-10-12 1993-10-12 Molecules influencing the shedding of the tnf receptor, their preparation and their use

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
IL10726893A IL107268D0 (en) 1993-10-12 1993-10-12 Molecules influencing the shedding of the tnf receptor, their preparation and their use
CA 2133872 CA2133872A1 (en) 1993-10-12 1994-10-07 Molecules influencing the shedding of the tnf receptor, their preparation and their use
DE1994627740 DE69427740T2 (en) 1993-10-12 1994-10-11 Inhibitors of a protease which cleaves the p55 soluble TNF receptor from the cell-bound TNF receptor
ES94116018T ES2163418T3 (en) 1993-10-12 1994-10-11 Inhibitors of a protease which is able to separate the soluble p55 TNF receptor TNF receptor bound to the cell.
PT94116018T PT657536E (en) 1993-10-12 1994-10-11 Inhibitors of a protease that is able to clivate the fnt soluble receiver p55 separating it of the fnt receptor connected to the cells
AT94116018T AT203273T (en) 1993-10-12 1994-10-11 Inhibitors of a protease which cleaves the p55 soluble TNF receptor from the cell-bound TNF receptor
DE1994627740 DE69427740D1 (en) 1993-10-12 1994-10-11 Inhibitors of a protease which cleaves the p55 soluble TNF receptor from the cell-bound TNF receptor
EP19940116018 EP0657536B1 (en) 1993-10-12 1994-10-11 Inhibitors of a protease which is capable of cleaving the soluble p55 TNF-receptor from cell-bound TNF-receptor
DK94116018T DK0657536T3 (en) 1993-10-12 1994-10-11 Inhibitors of a protease which is capable of cleaving the soluble p55 receptor from the cell-bound TNF receptor
AU75742/94A AU679559B2 (en) 1993-10-12 1994-10-11 Molecules influencing the shedding of the TNF receptor, their preparation and their use
US08/321,668 US5665859A (en) 1993-10-12 1994-10-12 Molecules influencing the shedding of the TNF receptor, their preparation and their use
JP6274532A JPH07194376A (en) 1993-10-12 1994-10-12 Molecule influencing shedding of tnf receptor, its preparation and its use
ZA9407962A ZA9407962B (en) 1993-10-12 1994-10-12 Molecules influencing the shedding of the TNF receptor their preparation and their use
US08/837,941 US5766917A (en) 1993-10-12 1997-04-28 Method for identifying and producing a protease capable of cleaving the TNF receptor
GR20010401643T GR3036782T3 (en) 1993-10-12 2001-10-03 Proteases capable of shedding the soluble TNF-receptor and TNF-R derived peptides and antibodies against the proteases inhibiting the shedding.

Publications (1)

Publication Number Publication Date
IL107268D0 true IL107268D0 (en) 1994-01-25

Family

ID=11065340

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10726893A IL107268D0 (en) 1993-10-12 1993-10-12 Molecules influencing the shedding of the tnf receptor, their preparation and their use

Country Status (13)

Country Link
US (2) US5665859A (en)
EP (1) EP0657536B1 (en)
JP (1) JPH07194376A (en)
AT (1) AT203273T (en)
AU (1) AU679559B2 (en)
CA (1) CA2133872A1 (en)
DE (2) DE69427740T2 (en)
DK (1) DK0657536T3 (en)
ES (1) ES2163418T3 (en)
GR (1) GR3036782T3 (en)
IL (1) IL107268D0 (en)
PT (1) PT657536E (en)
ZA (1) ZA9407962B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03164179A (en) * 1989-04-21 1991-07-16 Boehringer Ingelheim Internatl Gmbh Tnf receptor, tnf binding protein and dna encoding the same
US7264944B1 (en) * 1989-04-21 2007-09-04 Amgen Inc. TNF receptors, TNF binding proteins and DNAs coding for them
US6406855B1 (en) 1994-02-17 2002-06-18 Maxygen, Inc. Methods and compositions for polypeptide engineering
US5837458A (en) * 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US20050191661A1 (en) * 1996-11-06 2005-09-01 Tetsuya Gatanaga Treatment of inflammatory disease by cleaving TNF receptors
US6930084B1 (en) 1996-11-06 2005-08-16 The Regents Of The University Of California Treating arthritis with TNF receptor releasing enzyme
WO1998020140A1 (en) 1996-11-06 1998-05-14 The Regents Of The University Of California Isolated tumor necrosis factor receptor releasing enzyme, compositions comprising the enzyme and methods of the use thereof
US6593456B1 (en) * 1996-11-06 2003-07-15 The Regents Of The University Of California Tumor necrosis factor receptor releasing enzyme
US6989435B2 (en) * 1997-09-11 2006-01-24 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
KR100891899B1 (en) * 1998-05-14 2009-04-07 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 Factors affecting tumor necrosis factor receptor releasing enzyme activity
US6406907B1 (en) * 1999-02-26 2002-06-18 Iowa State University Research Foundation Bovine tumor necrosis factor receptor-1 and methods of use
AU4537101A (en) * 2000-02-28 2001-09-12 Us Health Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding
IL162133D0 (en) * 2001-11-30 2005-11-20 Applied Research Systems Method of increasing protein expression, proteins and polynucleotides
JP2009515523A (en) * 2005-11-10 2009-04-16 エルコレ バイオテック インコーポレイテッドErcole Biotech,Inc. Use of the oligomers in the splice switching oligomers and disease treatment for Tnf superfamily receptor
US7785834B2 (en) * 2005-11-10 2010-08-31 Ercole Biotech, Inc. Soluble TNF receptors and their use in treatment of disease
EP2021500B1 (en) * 2006-05-19 2014-12-31 Children, Youth and Women's Health Service Selective modulation of receptor signalling
US20090264353A1 (en) * 2007-10-19 2009-10-22 Santaris Pharma A/S Splice Switching Oligomers for TNF Superfamily Receptors and their Use in Treatment of Disease
JP5746191B2 (en) * 2009-10-19 2015-07-08 ハナル バイオファーマ カンパニーリミテッドHanAll Biopharma Co., Ltd. Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof and a manufacturing method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL101769A (en) * 1992-05-03 2007-02-11 Yeda Res & Dev Tnf receptor action modulation

Also Published As

Publication number Publication date
GR3036782T3 (en) 2002-01-31
AU679559B2 (en) 1997-07-03
AT203273T (en) 2001-08-15
DE69427740T2 (en) 2002-05-23
JPH07194376A (en) 1995-08-01
DE69427740D1 (en) 2001-08-23
CA2133872A1 (en) 1995-04-13
DK657536T3 (en)
EP0657536A1 (en) 1995-06-14
US5766917A (en) 1998-06-16
AU7574294A (en) 1995-05-04
EP0657536B1 (en) 2001-07-18
ES2163418T3 (en) 2002-02-01
DK0657536T3 (en) 2001-09-17
PT657536E (en) 2001-12-28
ZA9407962B (en) 1995-11-21
US5665859A (en) 1997-09-09

Similar Documents

Publication Publication Date Title
GB2221390B (en) Niacin-containing composition and its therapeutic use
AU672458B2 (en) Novel 3,3-diphenylpropylamines, their use and preparation
PL320263A1 (en) Dihydropyrimidines and their application
IL106849A (en) Carboxanilides their preparation and their use as fungicides
EP0591914A3 (en) Retrovirus of the hiv-group and its application
SG47033A1 (en) Film-enrobed unitary-core medicament and the like
AU5914590A (en) Muteins of human erythropoietin, the preparation thereof and the use thereof
ZA8907439B (en) Diethers usable in the preparation of ziegler-natta catalysts
HK1011361A1 (en) 1-biphenylmethylimidazole derivatives, their preparation and their therapeutic use
ZA9400711B (en) Heterocyclic compounds and their preparation and use
IL134685D0 (en) Anthracycline analogs and their use
GR3023691T3 (en) Lipopolyamines, their preparation and use
AU697482C (en) Human receptor H4-1BB
AU5233096A (en) Intermediates in the preparation of arylsulfonylureas and processes for their preparation
HRP960365B1 (en) New medicaments and the use thereof
AU3275093A (en) Spinal hook
EP0841941A4 (en) Novel non-pyrogenic bacterial strains and use of the same
ZA9809505B (en) Substituted isoquinoline-3-carboxamides their preparation and their use as pharmaceuticals
AU3176297A (en) Substituted 7-amino-pyrrolo{3,2-d}pyrimidines and the use thereof
GB9402331D0 (en) Nerve growth factor structural analogs and their uses
IL108144D0 (en) Non-reducing saccharideforming enzyme, its preparation and uses
DE69229724T2 (en) Highly absorbent materials and use the same
HU904853D0 (en) Enzymes and their use
GR3034528T3 (en) Human pf4a receptors and their use.
GR3029407T3 (en) Novel bioactive coatings and their preparation and use.